AstraZeneca stays mum on Medicare drug pricing negotiations

Medicare has started negotiating drug prices for the first time, but neither the government nor the drug makers are revealing details. Last week, Medicare made its first offers to 10 drug manufacturers, leaving it up to them to discuss the proposals. AstraZeneca executives did not disclose any details about the price negotiation for their diabetes drug Farxiga, saying they are in ongoing discussions with Medicare. They emphasized that they would not be disclosing the offer made by Medicare. This marks the first time Medicare has been involved in direct price negotiations with drug makers.

Source link

error: Content is protected !!